4.5 Article

Balb/c mice treated with D-cycloserine arouse increased social interest in conspecifics

期刊

BRAIN RESEARCH BULLETIN
卷 99, 期 -, 页码 95-99

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2013.10.006

关键词

D-Cycloserine; NMDA receptor; Sociability; Social preference; Balb/c mouse

资金

  1. Eastern Virginia Medical School
  2. Commonwealth Health Research Board of the Commonwealth of Virginia
  3. Office of the Dean of Eastern Virginia Medical School

向作者/读者索取更多资源

The genetically inbred Balb/cJ (Balb/c) mouse with functional alteration of its endogenous tone of NMDA receptor-mediated neurotransmission displays impaired sociability in a standard paradigm; this mouse strain has been proposed as a model of autism spectrum disorders (ASDs). Prior work showed that treatment of the Balb/c mouse with a centrally effective dose of D-cycloserine, a partial glycine(B) NMDA receptor agonist, improved several measures of its sociability. Additionally, D-cycloserine-treated Balb/c mice show greater preference for a social stimulus mouse than an inanimate object. We wondered if treatment with D-cycloserine also improved the social salience of the Balb/c mouse for normally sociable comparator strains. The current experiments explored whether C578I/6J (B6) and ICR mouse strains prefer D-cycloserine-treated to vehicle-treated Balb/c stimulus mice in a paradigm that evaluated social preference. The results showed that B6 mice prefer D-cycloserine-treated Balb/c mice to vehicle-treated Balb/c mice, suggesting that treatment could have resulted in normalization of emitted social cues. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

NMDA receptor activation regulates sociability by its effect on mTOR signaling activity

Jessica A. Burket, Andrew D. Benson, Amy H. Tang, Stephen I. Deutsch

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)

Article Clinical Neurology

Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism

Jessica A. Burket, Andrew D. Benson, Torrian L. Green, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Stephen I. Deutsch

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)

Article Neurosciences

Characterization of gait and olfactory behaviors in the Balb/c mouse model of autism spectrum disorders

Jessica A. Burket, Chelsea M. Young, Torrian L. Green, Andrew D. Benson, Stephen I. Deutsch

BRAIN RESEARCH BULLETIN (2016)

Article Neurosciences

Age-dependent effects on social interaction of NMDA GluN2A receptor subtype-selective antagonism

Torrian L. Green, Jessica A. Burket, Stephen I. Deutsch

BRAIN RESEARCH BULLETIN (2016)

Article Clinical Neurology

The 15q13.3 deletion syndrome: Deficient α7-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders

Stephen I. Deutsch, Jessica A. Burket, Andrew D. Benson, Maria R. Urbano

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)

Article Multidisciplinary Sciences

Experimental Assessment of Mouse Sociability Using an Automated Image Processing Approach

Frency Varghese, Jessica A. Burket, Andrew D. Benson, Stephen I. Deutsch, Christian W. Zemlin

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)

Review Clinical Neurology

Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder

Jessica A. Burket, Stephen I. Deutsch

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Editorial Material Clinical Neurology

Collaborative interdisciplinary approaches for a heterogeneous group of neurodevelopmental disorders; A Way forward!

Stephen I. Deutsch, Jessica A. Burket, Maria R. Urbano

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Article Clinical Neurology

Glycine transporter type 1 (GlyT1) inhibition improves conspecific-provoked immobility in BALB/c mice: Analysis of corticosterone response and glucocorticoid gene expression in cortex and hippocampus

Jessica A. Burket, Jerrah C. Pickle, Allison M. Rusk, Bronson A. Haynes, Julia A. Sharp, Stephen Deutsch

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)

Review Clinical Neurology

Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions

Stephen Deutsch, Jessica A. Burket

Summary: There is a growing expert consensus on prescribing and monitoring psychotropic medications for adults and older adults with intellectual disability (ID). However, there is limited empirical evidence to guide physicians in selecting specific categories of psychotropic medications for challenging behaviors. Challenges in applying diagnostic criteria and assigning psychiatric diagnoses to adults with ID lead to confusion surrounding medication selection. Long-term antipsychotic medication use is common for challenging behaviors, despite questionable efficacy, with some recommending short-term use for imminent dangerousness or threat to residential placements. Interdisciplinary treatment teams are essential for non-pharmacological plans and regular medication monitoring. Well-designed clinical trials are necessary for homogeneous samples, with a focus on safety and clinical outcomes. Innovative pharmacological strategies have been suggested to prevent adaptive function decline and improve cognition in adults with ID. Translational clinical trials addressing pathogenic mechanisms and challenging behaviors raise societal issues regarding protection of vulnerable populations and prioritization of therapeutic targets.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

Targeted NMDA Receptor Interventions for Autism: Developmentally Determined Expression of GluN2B and GluN2A-Containing Receptors and Balanced Allosteric Modulatory Approaches

Stephen Deutsch, Zachary N. M. Luyo, Jessica A. Burket

Summary: Various ASD risk alleles can lead to impairment of NMDA receptor activation, highlighting the need for the development of specific and selective translational therapeutic NMDA receptor agonists to restore balance.

BIOMOLECULES (2022)

Article Medicine, General & Internal

From Mouse to Man: N - Methyl-D-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum Disorders

Stephen I. Deutsch, Jessica A. Burket

MEDICAL CLINICS OF NORTH AMERICA (2023)

Article Biology

Exposure to Low (≤10 cGy) Doses of 4He Particles Leads to Increased Social Withdrawal and Loss of Executive Function Performance

Jessica A. Burket, Mona Matar, Arriyam Fesshaye, Jerrah C. Pickle, Richard A. Britten

Summary: Exposure to He particles can impact cognitive flexibility and social interaction in male rats, leading to deficits in executive functions and possibly affective behavior. These findings suggest that a single behavioral end point may not fully represent the cognitive deficits induced by space radiation.

RADIATION RESEARCH (2021)

Review Clinical Neurology

Sugarcoated Perineuronal Nets Regulate GABAergic Transmission: Bittersweet Hypothesis in Autism Spectrum Disorder

Jessica A. Burket, Maria R. Urbano, Stephen I. Deutsch

CLINICAL NEUROPHARMACOLOGY (2017)

Review Clinical Neurology

NMDA agonists for autism spectrum disorders: progress and possibilities

Stephen I. Deutsch, Jessica A. Burket, Andrew D. Benson, Maria R. Urbano

FUTURE NEUROLOGY (2015)

暂无数据